Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Burning Rock Biotech Ltd ADR (NQ: BNR )

2.210 -0.020 (-0.90%)
Streaming Delayed Price Updated: 2:21 PM EDT, Jun 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,836
Open 2.220
Bid (Size) 2.210 (12)
Ask (Size) 2.260 (1)
Prev. Close 2.230
Today's Range 2.140 - 2.290
52wk Range 1.700 - 4.240
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine
From Burning Rock Biotech Limited
Via GlobeNewswire
Earnings Scheduled For May 30, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its first quarter. 
Via Benzinga

Performance

YTD
+2.31%
+2.31%
1 Month
-25.34%
-25.34%
3 Month
-23.79%
-23.79%
6 Month
-16.60%
-16.60%
1 Year
+2.79%
+2.79%

More News

Read More
Burning Rock Reports First Quarter 2023 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Earnings Preview: Burning Rock Biotech
Via Benzinga
Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Publishes 2022 Annual Report on Form 20-F
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock provides an update on 2022 revenue guidance
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test
From Burning Rock Biotech Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Burning Rock Reports Third Quarter 2022 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Admission to Trading on the London Stock Exchange
From Burning Rock Biotech Limited
Via GlobeNewswire
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Burning Rock Announces Publication of Prospectus in connection with Direct Listing on the London Stock Exchange
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Provides Third Quarter 2022 Business Updates and Schedules Earnings Release on November 16, 2022
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces Publication of Registration Document and Potential Direct Listing on the London Stock Exchange
From Burning Rock Biotech Limited
Via GlobeNewswire
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Livent, Amgen And Some Other Big Stocks Moving Lower On Monday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Drops 100 Points; US Crude Oil Inventories Decline Higher-Than-Expected Last Week
Via Benzinga
Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday
Via Benzinga
Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.